{"nctId":"NCT00734214","briefTitle":"Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial","startDateStruct":{"date":"2008-03"},"conditions":["Hyponatremia","Hypernatremia"],"count":258,"armGroups":[{"label":"0.9% NaCl","type":"EXPERIMENTAL","interventionNames":["Drug: 0.9% NaCl"]},{"label":"0.45% NaCl","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: 0.45%NaCl"]}],"interventions":[{"name":"0.9% NaCl","otherNames":["Isotonic saline"]},{"name":"0.45%NaCl","otherNames":["Hypotonic saline"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Pediatric patients, 6 months corrected age -16 years, undergoing surgery.\n* Within 6 hours of the immediate post-operative period.\n* Post-operative stay anticipated to be more than 24 hours.\n* Primary route of fluid administration is anticipated to be intravenous, in the first 24 hours following surgery.\n* Informed consent of parent/guardian.\n* Consent to participate from surgeon.\n\nExclusion Criteria:\n\n* Patients under 6 months of age\n* Patients equal to or over 17 years of age\n* Patients with hemodynamic instability , defined as a requirement for continuous vasoactive infusion (e.g. epinephrine, dopamine, norepinephrine, phenylephrine, milrinone, or Dobutamine) to maintain blood pressure at the end of surgery.\n* Patients admitted into the \"short stay\" post-operative unit\n* Patients in whom either hypotonic or isotonic solutions may be contraindicated/necessary: i.e. specific neurosurgical patients (ie those at risk of increased ICP, e.g. requiring actual brain surgery, ICP monitor or external ventricular drain insertion), patients with diabetic ketoacidosis, acute (≤ 7 days) burns, pre-existing CHF, liver failure or cirrhosis, renal failure.\n* Patients with known pre-existing risk of PNa derangements: DI or SIADH\n* Chronic diuretic use - defined as use of any oral or intravenous diuretics for ≥ 7 days.\n* Known, uncorrected PNa derangement (PNa \\< 134 or \\> 146 mmol/L), identified peri-operatively (i.e. within 12 hours of surgery or during surgery).\n* Prior enrolment in this study\n* Patients or their guardians objecting to give consent.","healthyVolunteers":true,"sex":"ALL","minimumAge":"6 Months","maximumAge":"16 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Hospital Acquired Acute Plasma Sodium Derangements (Hypo- or Hypernatremia)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Adjudicated Morbidity Attributed to Acute Plasma Sodium Changes.","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"PRIMARY","title":"Hyponatremia","description":"Plasma sodium less than 135 mmol/L","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null},{"groupId":"OG001","value":"53","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":128},"commonTop":["Generalized Edema","New onset Hypertension"]}}}